Literature DB >> 8026253

Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome.

M J Collen1, R T Jensen.   

Abstract

Many patients with acid-peptic disease have idiopathic gastric acid hypersecretion defined as a basal acid output > 10.0 meq/hr; however, a significant proportion have basal acid outputs > 15.0 meq/hr, which is within the range found in Zollinger-Ellison syndrome. Although idiopathic gastric acid hypersecretion is more common than Zollinger-Ellison syndrome, it is important that these two disorders be differentiated because of differences in treatment and natural history. In the present study, we compared 124 patients with idiopathic gastric acid hypersecretion and 137 patients with Zollinger-Ellison syndrome. There were no significant differences with regard to age at diagnosis, history of upper gastrointestinal hemorrhage, nausea, vomiting, and family history of duodenal ulcer and other acid-peptic disease. However, significant differences were observed between patients with idiopathic gastric acid hypersecretion and patients with Zollinger-Ellison syndrome with regard to percentage of males: 77% compared to 64% (P = 0.008), mean serum gastrin: 60 pg/ml compared to 3679 pg/ml (normal < 100 pg/ml) (P < 0.001), mean basal acid output: 15.4 meq/hr compared to 47.0 meq/hr (P < 0.001), mean age at onset of symptoms: 33 years compared to 41 years (P < 0.001), mean duration of symptoms before diagnosis: 11 years compared to five years (P < 0.001), percentage with abdominal pain: 67% compared to 82% (P = 0.00004), percentage with diarrhea: 12% compared to 75% (P < 0.000001), percentage with pyrosis: 58% compared to 40% (P = 0.003), percentage with duodenal ulcer: 53% compared to 74% (P < 0.000001), and percentage with esophagitis: 31% compared to 42% (P = 0.0004).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026253     DOI: 10.1007/bf02088045

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Decision analysis in evaluation of hypergastrinemia.

Authors:  E Spindel; R F Harty; J R Leibach; J E McGuigan
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

2.  Gastric analysis (basal acid output) in nonulcer dyspepsia.

Authors:  M J Collen
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

3.  Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).

Authors:  M J Collen; V J Stanczak; C A Ciarleglio
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

4.  Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis.

Authors:  M J Collen; M J Loebenberg
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

5.  Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.

Authors:  J P Raufman; S M Collins; S J Pandol; L Y Korman; M J Collen; M J Cornelius; M K Feld; D M McCarthy; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

6.  Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.

Authors:  M J Collen; D A Johnson
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

7.  Bleeding duodenal ulcer. Role of gastric acid hypersecretion.

Authors:  M J Collen; A N Kalloo; M J Sheridan
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

8.  Basal gastric acid secretion in children with atypical epigastric pain.

Authors:  M J Collen; C A Ciarleglio; V J Stanczak; W R Treem; J H Lewis
Journal:  Am J Gastroenterol       Date:  1988-09       Impact factor: 10.864

9.  Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.

Authors:  P N Maton; R Vinayek; H Frucht; K A McArthur; L S Miller; Z A Saeed; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

10.  Gastric ulcers differ from duodenal ulcers. Evaluation of basal acid output.

Authors:  M J Collen; M J Sheridan
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

View more
  5 in total

Review 1.  Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.

Authors:  Aaron H Mendelson; Mark Donowitz
Journal:  Dig Dis Sci       Date:  2017-08-03       Impact factor: 3.199

2.  Mechanism of acid hypersecretion post curative gastrinoma resection.

Authors:  Jeremiah V Ojeaburu; Tetsuhide Ito; Pellegrino Crafa; Cesare Bordi; Robert T Jensen
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

3.  Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.

Authors:  B Dave; W Rubin
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

4.  Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.

Authors:  M J Collen; J F Wirshup
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  Gastric Hypersecretory States: Investigation and Management.

Authors:  Jennifer Phan; Jihane N Benhammou; Joseph R Pisegna
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.